Ex-Head of F.D.A. Faces Criminal Inquiry

His abrupt departure as FDA Commissioner occurred under a cloud of controversy abut reports of undisclosed stock

January 28, 2006

U.S. Subpoena Opens a New Front in Investigation ofGuidant Heart Devices

The New York Times reports that federal prosecutors had merged their inquiry with an earlier one by

January 3, 2006

All contributed toward exposing industry front groups that pose as "patient advocacy" groups, and on Dec. 30

January 3, 2006

Lisa Krinsky resigned as president, and Arnold Hantman as its chief executive. On Dec. 19, Gerald Seifer,

December 15, 2005

The case involves SFBC, which runs the largest clinical trial site in North America, the site is

May 20, 2005

Fri, 20 May 2005 ARMA was a government-sponsored, $41 million experiment involving 861 critically ill patients with